Nu Skin Enterprises (NUS) Shares Down 13.7% on Disappointing Earnings

Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) were down 13.7% on Thursday after the company announced weaker than expected quarterly earnings. The company traded as low as $61.85 and last traded at $62.84. Approximately 986,430 shares traded hands during trading, an increase of 113% from the average daily volume of 463,262 shares. The stock had previously closed at $72.82.

The company reported $0.94 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.96 by ($0.02). Nu Skin Enterprises had a return on equity of 25.67% and a net margin of 5.74%. The company had revenue of $675.31 million for the quarter, compared to analyst estimates of $664.99 million. During the same quarter in the prior year, the business earned $0.76 earnings per share. Nu Skin Enterprises’s revenue was up 19.8% compared to the same quarter last year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 12th. Investors of record on Friday, November 30th will be paid a dividend of $0.365 per share. The ex-dividend date is Thursday, November 29th. This represents a $1.46 annualized dividend and a yield of 2.25%. Nu Skin Enterprises’s dividend payout ratio is currently 45.20%.

Several equities research analysts recently commented on NUS shares. Stifel Nicolaus upgraded shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and lifted their price target for the stock from $57.00 to $70.00 in a research note on Thursday, August 2nd. They noted that the move was a valuation call. Jefferies Financial Group set a $98.00 price target on shares of Nu Skin Enterprises and gave the stock a “buy” rating in a research note on Friday, August 3rd. Zacks Investment Research upgraded shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and set a $95.00 price target on the stock in a research note on Monday, August 6th. DA Davidson started coverage on shares of Nu Skin Enterprises in a research note on Tuesday, October 9th. They set a “buy” rating and a $92.00 price target on the stock. Finally, Citigroup set a $88.00 price target on shares of Nu Skin Enterprises and gave the stock a “buy” rating in a research note on Thursday. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and five have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $86.29.

In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 2,500 shares of Nu Skin Enterprises stock in a transaction on Monday, October 1st. The shares were sold at an average price of $82.18, for a total value of $205,450.00. Following the transaction, the general counsel now directly owns 33,871 shares in the company, valued at $2,783,518.78. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 5.20% of the company’s stock.

Hedge funds and other institutional investors have recently bought and sold shares of the business. Harvest Fund Management Co. Ltd increased its stake in Nu Skin Enterprises by 162.9% in the third quarter. Harvest Fund Management Co. Ltd now owns 1,291 shares of the company’s stock valued at $106,000 after purchasing an additional 800 shares during the period. Global X Management Co LLC increased its stake in Nu Skin Enterprises by 141.9% in the second quarter. Global X Management Co LLC now owns 1,732 shares of the company’s stock valued at $135,000 after purchasing an additional 1,016 shares during the period. First Hawaiian Bank acquired a new position in Nu Skin Enterprises in the third quarter valued at $165,000. Ffcm LLC increased its stake in Nu Skin Enterprises by 181.9% in the third quarter. Ffcm LLC now owns 1,911 shares of the company’s stock valued at $177,000 after purchasing an additional 1,233 shares during the period. Finally, Engineers Gate Manager LP acquired a new position in Nu Skin Enterprises in the third quarter valued at $204,000. Institutional investors own 76.47% of the company’s stock.

The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.19 and a current ratio of 1.82. The company has a market cap of $4.04 billion, a P/E ratio of 20.13, a price-to-earnings-growth ratio of 1.78 and a beta of 1.04.

TRADEMARK VIOLATION WARNING: This piece was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2018/11/10/nu-skin-enterprises-nus-shares-down-13-7-on-disappointing-earnings.html.

Nu Skin Enterprises Company Profile (NYSE:NUS)

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.

See Also: Cash Flow

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply